Michael F Lahn

Title: Michael F Lahn: Innovator in Airway Hyperresponsiveness Treatment

Introduction

Michael F Lahn is a notable inventor based in Zionsville, IN (US). He has made significant contributions to the field of medical research, particularly in the treatment of airway hyperresponsiveness. With a total of 3 patents, Lahn's work focuses on innovative methods to improve respiratory health.

Latest Patents

Lahn's latest patents include a method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies. This method involves the direct delivery of aerosolized antibodies to the lungs, effectively reducing airway hyperresponsiveness associated with allergic inflammation. It is particularly advantageous as it operates at extremely low doses of antibody and does not significantly impact the peripheral immune system. Another significant patent is related to the modulation of gamma delta T cells to regulate airway hyperresponsiveness. This patent discloses methods for identifying compounds that can regulate airway hyperresponsiveness by modulating the action of gamma delta T cells in patients.

Career Highlights

Throughout his career, Michael F Lahn has worked with esteemed organizations such as National Jewish Health and the National Jewish Medical and Research Center. His research has been pivotal in advancing the understanding and treatment of respiratory conditions.

Collaborations

Lahn has collaborated with notable colleagues, including Willi K Born and Arihiko Kanehiro, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Michael F Lahn's innovative approaches to treating airway hyperresponsiveness highlight his dedication to improving patient outcomes in respiratory health. His patents and collaborations reflect a commitment to advancing medical research and innovation.